Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.
Stephen Curry, MD, PhD
Combining Enhanced Neurotransmission and Inhibition of Beta Amyloid Toxicity in Treating Cognitive Disorders in Alzheimer's Disease
A GuideStar-Rated Charity
© Copyright 2026. The Alzheimer's Drug Discovery Foundation, a not-for-profit, section 501 (c)(3).